MTND5P19: A Drug Target / Disease Biomarker (G100873270)

Target Name: MTND5P19

NCBI ID: G100873270

MTND5P19

Other Name(s): MT-ND5 pseudogene 19 | Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5 pseudogene 19

MTND5P19: A Drug Target / Disease Biomarker

MTND5P19 is a protein that is expressed in the brain and is known for its role in the development and progression of multiple sclerosis (MS). The protein is named after its primary structure, which consists of 588 amino acids.

MS is a chronic and debilitating disease that affects the central nervous system and can cause a range of symptoms, including muscle weakness, vision problems, and fatigue. Currently, there is no cure for MS, and treatment is focused on managing symptoms and preventing complications.

MTND5P19 has been shown to be involved in the development and progression of MS by regulating the activity of immune cells in the brain. Studies have shown thatMTND5P19 is highly expressed in the brain and that its levels are decreased in individuals with MS.

Additionally, MTND5P19 has been shown to play a role in the regulation of pain perception and neuroinflammation. This suggests that it may be involved in the development and progression of MS as a result of neuroinflammation.

Despite the potential implications of MTND5P19 as a drug target or biomarker, more research is needed to fully understand its role in MS. Further studies are needed to determine the exact mechanism of MTND5P19's involvement in MS and to explore its potential as a therapeutic target.

In conclusion, MTND5P19 is a protein that has the potential to be a drug target or biomarker for MS. Further research is needed to fully understand its role in the development and progression of MS and to explore its potential as a therapeutic target.

Protein Name: MT-ND5 Pseudogene 19

The "MTND5P19 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MTND5P19 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets